EVA MARIA RIVERA: Open Payments
NPI 1437780996 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 13 payments from 9 companies in 2025. Trend: 2023 $27 · 2024 $308 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $161 |
| Neurocrine BioSciences, Inc. | 1 | $146 |
| Eisai Inc. | 2 | $45 |
| EMD Serono, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $28 |
| Novo Nordisk Inc | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
Products named: INGREZZA, QULIPTA, Leqembi, VYEPTI, Ozempic, TYSABRI, ACTHAR, UBRELVY.
Industry payments across NV — which companies pay providers there.
